• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥密克戎变异株 BA.1 刺突突变对小鼠 T 细胞表位的影响。

Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice.

机构信息

Beijing Institute of Biotechnology, Beijing 100071, China.

出版信息

Viruses. 2023 Mar 16;15(3):763. doi: 10.3390/v15030763.

DOI:10.3390/v15030763
PMID:36992472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10056712/
Abstract

T-cell immunity plays an important role in the control of SARS-CoV-2 and has a great cross-protective effect on the variants. The Omicron BA.1 variant contains more than 30 mutations in the spike and severely evades humoral immunity. To understand how Omicron BA.1 spike mutations affect cellular immunity, the T-cell epitopes of SARS-CoV-2 wild-type and Omicron BA.1 spike in BALB/c (H-2) and C57BL/6 mice (H-2) were mapped through IFNγ ELISpot and intracellular cytokine staining assays. The epitopes were identified and verified in splenocytes from mice vaccinated with the adenovirus type 5 vector encoding the homologous spike, and the positive peptides involved in spike mutations were tested against wide-type and Omicron BA.1 vaccines. A total of eleven T-cell epitopes of wild-type and Omicron BA.1 spike were identified in BALB/c mice, and nine were identified in C57BL/6 mice, only two of which were CD4 T-cell epitopes and most of which were CD8 T-cell epitopes. The A67V and Del 69-70 mutations in Omicron BA.1 spike abolished one epitope in wild-type spike, and the T478K, E484A, Q493R, G496S and H655Y mutations resulted in three new epitopes in Omicron BA.1 spike, while the Y505H mutation did not affect the epitope. These data describe the difference of T-cell epitopes in SARS-CoV-2 wild-type and Omicron BA.1 spike in H-2 and H-2 mice, providing a better understanding of the effects of Omicron BA.1 spike mutations on cellular immunity.

摘要

T 细胞免疫在控制 SARS-CoV-2 中发挥着重要作用,对变异株具有很强的交叉保护作用。Omicron BA.1 变体在刺突蛋白中包含 30 多个突变,严重逃避了体液免疫。为了了解 Omicron BA.1 刺突突变如何影响细胞免疫,通过 IFNγ ELISpot 和细胞内细胞因子染色测定,在 BALB/c(H-2)和 C57BL/6 小鼠(H-2)中对 SARS-CoV-2 野生型和 Omicron BA.1 刺突的 T 细胞表位进行了定位。在腺病毒 5 型载体编码同源刺突的疫苗接种小鼠的脾细胞中鉴定和验证了这些表位,并针对野生型和 Omicron BA.1 疫苗测试了涉及刺突突变的阳性肽。在 BALB/c 小鼠中鉴定到野生型和 Omicron BA.1 刺突的 11 个 T 细胞表位,在 C57BL/6 小鼠中鉴定到 9 个 T 细胞表位,其中只有 2 个是 CD4 T 细胞表位,大部分是 CD8 T 细胞表位。Omicron BA.1 刺突中的 A67V 和 Del 69-70 突变使野生型刺突中的一个表位失活,而 T478K、E484A、Q493R、G496S 和 H655Y 突变导致 Omicron BA.1 刺突中出现 3 个新表位,而 Y505H 突变不影响表位。这些数据描述了 SARS-CoV-2 野生型和 Omicron BA.1 刺突在 H-2 和 H-2 小鼠中的 T 细胞表位差异,为更好地了解 Omicron BA.1 刺突突变对细胞免疫的影响提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4279/10056712/5461598dc420/viruses-15-00763-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4279/10056712/7a513c3fed37/viruses-15-00763-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4279/10056712/db75228184c9/viruses-15-00763-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4279/10056712/f958c6c51d9a/viruses-15-00763-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4279/10056712/655e27f07f3c/viruses-15-00763-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4279/10056712/5461598dc420/viruses-15-00763-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4279/10056712/7a513c3fed37/viruses-15-00763-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4279/10056712/db75228184c9/viruses-15-00763-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4279/10056712/f958c6c51d9a/viruses-15-00763-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4279/10056712/655e27f07f3c/viruses-15-00763-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4279/10056712/5461598dc420/viruses-15-00763-g005.jpg

相似文献

1
Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice.奥密克戎变异株 BA.1 刺突突变对小鼠 T 细胞表位的影响。
Viruses. 2023 Mar 16;15(3):763. doi: 10.3390/v15030763.
2
SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals.新冠病毒奥密克戎变异株 BA.4/BA.5 刺突突变导致近期接种疫苗个体 T 细胞逃逸。
Viruses. 2022 Dec 29;15(1):101. doi: 10.3390/v15010101.
3
Landscape of T cell epitopes displays hot mutations of SARS-CoV-2 variant spikes evading cellular immunity.细胞表位景观显示逃避细胞免疫的 SARS-CoV-2 变体刺突的热点突变。
J Med Virol. 2024 Feb;96(2):e29452. doi: 10.1002/jmv.29452.
4
Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.奥密克戎 BA.1 突变使 SARS-CoV-2 刺突蛋白减少,导致接种疫苗和康复个体的 T 细胞反应降低。
Viruses. 2022 Jul 19;14(7):1570. doi: 10.3390/v14071570.
5
Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 T-Cell Epitopes Identified in COVID-19 Convalescent Individuals.在 COVID-19 康复个体中鉴定的与 SARS-CoV-2 的奥密克戎变异株相关的突变和 CD8 T 细胞表位之间最小交叉。
mBio. 2022 Apr 26;13(2):e0361721. doi: 10.1128/mbio.03617-21. Epub 2022 Mar 1.
6
A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population.SARS-CoV-2 变体中 T 细胞表位多样性的生物信息学分析:与美国人群中 COVID-19 临床严重程度的关联。
Front Immunol. 2024 May 9;15:1357731. doi: 10.3389/fimmu.2024.1357731. eCollection 2024.
7
SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein.严重急性呼吸综合征冠状病毒2型奥密克戎毒株(BA.1和BA.2)靶向刺突蛋白的特异性新型CD8+和CD4+T细胞表位
Immunoinformatics (Amst). 2022 Dec;8:100020. doi: 10.1016/j.immuno.2022.100020. Epub 2022 Nov 1.
8
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2.导致 SARS-CoV-2 奥密克戎 BA.1 和 BA.2 进入偏好改变的 Spike 突变。
Emerg Microbes Infect. 2022 Dec;11(1):2275-2287. doi: 10.1080/22221751.2022.2117098.
9
Discrimination of SARS-CoV-2 omicron variant and its lineages by rapid detection of immune-escape mutations in spike protein RBD using asymmetric PCR-based melting curve analysis.利用基于不对称 PCR 的熔解曲线分析快速检测刺突蛋白 RBD 中的免疫逃逸突变来区分 SARS-CoV-2 奥密克戎变异株及其谱系。
Virol J. 2023 Aug 25;20(1):192. doi: 10.1186/s12985-023-02137-5.
10
Cross-Reactivity Assessment of Vaccine-Derived SARS-CoV-2 T Cell Responses against BA.2.86 and JN.1.疫苗衍生的 SARS-CoV-2 T 细胞反应对 BA.2.86 和 JN.1 的交叉反应性评估
Viruses. 2024 Mar 20;16(3):473. doi: 10.3390/v16030473.

引用本文的文献

1
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection.一种二价新冠病毒mRNA疫苗引发了广泛的免疫反应并提供了针对奥密克戎亚变体感染的保护。
NPJ Vaccines. 2025 Jan 10;10(1):4. doi: 10.1038/s41541-025-01062-8.
2
Identification of mouse CD4 T cell epitopes in SARS-CoV-2 BA.1 spike and nucleocapsid for use in peptide:MHCII tetramers.鉴定 SARS-CoV-2 BA.1 刺突蛋白和核衣壳中的小鼠 CD4 T 细胞表位,用于肽:MHCII 四聚体。
Front Immunol. 2024 Mar 11;15:1329846. doi: 10.3389/fimmu.2024.1329846. eCollection 2024.
3
An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants.

本文引用的文献

1
Humoral and cellular immune responses against SARS-CoV-2 variants of concern induced by heterologous CoronaVac/ChAdOx-1 versus homologous ChAdOx-1 vaccination in the elderly.在老年人中,异源 CoronaVac/ChAdOx-1 疫苗接种与同源 ChAdOx-1 疫苗接种相比,针对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)变异株所引发的体液免疫和细胞免疫反应。
Asian Pac J Allergy Immunol. 2023 Feb 11. doi: 10.12932/AP-120822-1434.
2
ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5.XBB.1.5增强传播性中的ACE2结合与抗体逃逸
Lancet Infect Dis. 2023 Mar;23(3):278-280. doi: 10.1016/S1473-3099(23)00010-5. Epub 2023 Feb 3.
3
一种编码严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域的信使核糖核酸(mRNA)疫苗可保护小鼠免受多种奥密克戎变体的侵害。
NPJ Vaccines. 2024 Jan 2;9(1):4. doi: 10.1038/s41541-023-00800-0.
4
During the Omicron Pandemic Wave, the Severe Systemic Inflammatory Status of COVID-19 Indicated a Higher Risk of In-Hospital Mortality and Mediated the Clinical Efficacy of Corticosteroids.在奥密克戎大流行期间,新冠病毒病的严重全身炎症状态表明住院死亡率较高,并介导了皮质类固醇的临床疗效。
Infect Drug Resist. 2023 Nov 30;16:7377-7387. doi: 10.2147/IDR.S432679. eCollection 2023.
5
Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport during Three Pandemic Waves in Italy.意大利三次疫情浪潮期间空军机场军事和文职人员中新型冠状病毒变异株的特征分析
Microorganisms. 2023 Nov 5;11(11):2711. doi: 10.3390/microorganisms11112711.
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.
令人担忧的 SARS-CoV-2 BQ 和 XBB 亚型不断出现的抗体逃逸特性。
Cell. 2023 Jan 19;186(2):279-286.e8. doi: 10.1016/j.cell.2022.12.018. Epub 2022 Dec 14.
4
Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB.奥密克戎亚变体BQ.1.1和XBB的体液免疫逃逸
Lancet Infect Dis. 2023 Jan;23(1):30-32. doi: 10.1016/S1473-3099(22)00816-7. Epub 2022 Dec 7.
5
Current understanding of T cell immunity against SARS-CoV-2.目前对T细胞针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)免疫反应的理解。
Inflamm Regen. 2022 Nov 29;42(1):51. doi: 10.1186/s41232-022-00242-6.
6
Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA.4/5/2.75 subvariants in BA.2 breakthrough infections.野生型 SARS-CoV-2 疫苗的抗原性错误导致 BA.2 突破感染对 BA.4/5/2.75 亚系的交叉中和作用较差。
Nat Commun. 2022 Nov 19;13(1):7120. doi: 10.1038/s41467-022-34400-8.
7
Omicron Subvariants, Including BA.4 and BA.5, Substantially Preserve T Cell Epitopes of Ancestral SARS-CoV-2.包括BA.4和BA.5在内的奥密克戎亚变体基本保留了原始新冠病毒的T细胞表位。
Immune Netw. 2022 Aug 3;22(4):e29. doi: 10.4110/in.2022.22.e29. eCollection 2022 Aug.
8
Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope.主要 SARS-CoV-2 杀伤性 T 细胞表位出现免疫逃逸。
Cell. 2022 Aug 4;185(16):2936-2951.e19. doi: 10.1016/j.cell.2022.07.002. Epub 2022 Jul 14.
9
Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs.新兴 SARS-CoV-2 变异株刺突蛋白的 Ad5 载体诱导的抗体反应的比较特征。
Signal Transduct Target Ther. 2022 Jul 29;7(1):257. doi: 10.1038/s41392-022-01065-0.
10
Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.奥密克戎 BA.1 突变使 SARS-CoV-2 刺突蛋白减少,导致接种疫苗和康复个体的 T 细胞反应降低。
Viruses. 2022 Jul 19;14(7):1570. doi: 10.3390/v14071570.